Skip to main content

Val R. Adams, PharmD, BCOP, FCCP, FHOPA

Authored Items
Treatment of Advanced Breast Cancer: A Clinical Pharmacy Perspective
Val R. Adams, PharmD, BCOP, FCCP, FHOPA, Allison R. Butts, PharmD, BCOP
Review of Ribociclib for Advanced Hormone Receptor–Positive Breast Cancer in Perspective
Translation of Benchtop Science Arrives in Force, Improves Patient Care
Val R. Adams, PharmD, BCOP, FCCP, FHOPA
2016 First Annual Oncology Guide to New FDA Approvals in FDA Updates
Cancer Therapy: Adverse Event Prevention and Management Education for All Pharmacists
Val R. Adams, PharmD, BCOP, FCCP, FHOPA
JHOP - September 2014 Vol 4, No 3
Predictors for Severe Tumor Lysis Syndrome
Scott Wirth, PharmD, BCOP, Douglas T. Steinke, PhD, Amber P. Lawson, PharmD, Stephanie D. Sutphin, PharmD, Michael D. Blechner, MD, Val R. Adams, PharmD, BCOP, FCCP, FHOPA
JHOP - June 2012, Vol 2, No 2 in Original Research
Bevacizumab in Metastatic Breast Cancer: Ready for Prime Time?
Katherine Mandock, PharmD, BCPS, Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, Val R. Adams, PharmD, BCOP, FCCP, FHOPA
JHOP - December 2011 VOL 1, NO 4 in Breast Cancer
Introducing the Journal of Hematology Oncology Pharmacy
Patrick J. Medina, PharmD, BCOP, FHOPA, Val R. Adams, PharmD, BCOP, FCCP, FHOPA
JHOP - March 2011, Vol 1, No 1
Last modified: August 29, 2024